Form 4: Tevogen Bio CEO Gifts 460K Shares to Charities

Tevogen Bio Holdings Inc. CEO Ryan H. Saadi reported gifting 460,000 shares of common stock to two charitable organizations on December 11, 2025, under a Rule 10b5-1 plan.

Summary

• Ryan H. Saadi, who serves as Chief Executive Officer, Director, and a 10% Owner of Tevogen Bio Holdings Inc. (TVGN), reported a disposition of common stock.
• On December 11, 2025, Saadi gifted a total of 460,000 shares of Tevogen Bio common stock.
• The transaction was a gift (Transaction Code G) with a reported price of $0 per share.
• The shares were distributed equally, with 230,000 shares each, to two charitable entities: Shrimad Rajchandra Love and Care USA, Inc. and Warren Township Honorary P.B.A., Inc.
• This transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged contract or instruction for the disposition of securities.
• Following this gift, Saadi directly beneficially owns 124,334,453.322 shares and indirectly owns 193,924 shares through his wife.

Sentiment

Score: 6

Explanation: The filing reports a charitable gift by the CEO, which is generally viewed positively from a public relations perspective, though it represents a reduction in direct insider ownership. It does not reflect on the company's operational or financial performance.

Positives

• Demonstrates philanthropic activity by the CEO, potentially enhancing the company's public image through association with charitable giving.

Negatives

• Represents a reduction in the CEO's direct beneficial ownership, although for a charitable purpose.

Risks

• No specific risks are mentioned in this Form 4 filing. The transaction itself is a routine disclosure of insider activity.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or the competitive landscape. It reflects an individual's personal financial planning and philanthropic activities.

Stakeholder Impact

• Shareholders: A minor reduction in the CEO's direct beneficial ownership, offset by the positive optics of charitable giving.
• Charitable Organizations: Direct beneficiaries of the stock gift.

Key Dates

Keywords

Tevogen Bio, TVGN, Ryan H. Saadi, Insider Transaction, Form 4, Stock Gift, Charitable Donation, Beneficial Ownership, Rule 10b5-1